Patterns of disease activity in systemic lupus erythematosus

被引:0
|
作者
Barr, SG
Zonana-Nacach, A
Magder, LS
Petri, M
机构
[1] Johns Hopkins Univ, Sch Med, Div Mol & Clin Rheumatol, Baltimore, MD 21205 USA
[2] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
来源
ARTHRITIS AND RHEUMATISM | 1999年 / 42卷 / 12期
关键词
D O I
10.1002/1529-0131(199912)42:12<2682::AID-ANR26>3.0.CO;2-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To describe patterns of systemic lupus (SLE) disease activity over time. Methods. Disease activity was measured in a prospective cohort of 204 consecutive SLE patients followed up quarterly for 2.0-7.5 years (911 person-years of followup), Physician's global assessment (PGA) and modified SLE Disease Activity Index (M-SLEDAI; omitting serology) scores were plotted against time for each patient, Definitions for disease activity patterns were developed by consensus using these plots, and the proportion of total followup time represented by each pattern was calculated. Results. Three patterns of SLE activity were apparent: relapsing-remitting (RR), chronic active (CA), and long quiescent (LQ), The CA pattern was the most frequent for both the PGA and M-SLEDAI, representing 58% and 40% of total person-years, respectively, The least common pattern was LQ (PGA 16%, M-SLEDAI 25%), while the RR pattern was intermediate in frequency (PGA 26%, M-SLEDAI 35%). Average disease activity during RR periods tended to be mild, while that during CA periods was more likely to be moderately severe, The most common discrepancy between instruments was that the PGA depicted CA when the M-SLEDAI showed an RR pattern. The M-SLEDAI did not appear to capture mild degrees of activity. Conclusion. SLE activity was readily classified into 1 of 3 patterns: RR,CA, or LQ, The CA pattern,vas most common, suggesting that significant morbidity may arise from persistent disease activity. These findings may have important implications regarding the choice of outcome measures in SLE clinical trials, since comparison of flare rates may not account for chronic disease activity.
引用
收藏
页码:2682 / 2688
页数:7
相关论文
共 50 条
  • [31] Predictors of disease activity and disease damage in pediatric systemic lupus erythematosus
    Hiraki, L. T.
    Benseler, S. M.
    Tyrrell, P. N.
    Hebert, D.
    Harvey, E.
    Silverman, E. D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 116 - 116
  • [32] FAR in systemic lupus erythematosus: a potential biomarker of disease activity and lupus nephritis
    Xu, Jili
    Zhang, Hongmei
    Che, Nan
    Wang, Hengjin
    [J]. CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (08) : 4779 - 4785
  • [33] FAR in systemic lupus erythematosus: a potential biomarker of disease activity and lupus nephritis
    Jili Xu
    Hongmei Zhang
    Nan Che
    Hengjin Wang
    [J]. Clinical and Experimental Medicine, 2023, 23 : 4779 - 4785
  • [34] Neurotrophic factors in systemic lupus erythematosus: markers of disease activity
    Dias, A. F. M. P.
    Lanna, C. C. D.
    Teixeira, A. L.
    Ferreira, G. A.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (06) : 1451 - 1452
  • [35] Cutaneous Manifestations Associated with Systemic Lupus Erythematosus Disease Activity
    Sowerby, L.
    O'Brien, E.
    Joseph, L.
    Bernatskyz, S.
    Nashi, E.
    Vinet, E.
    Clarke, A. E.
    Pineau, C. A.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 (05) : 1487 - 1487
  • [36] DISEASE ACTIVITY INDICES (DAIS) IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    Wyrwich, K.
    Winnette, R.
    Oglesby, A.
    Narayanan, S.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A508 - A508
  • [37] Measures of Adult Systemic Lupus Erythematosus: Disease Activity and Damage
    Arora, Shilpa
    Isenberg, David A.
    Castrejon, Isabel
    [J]. ARTHRITIS CARE & RESEARCH, 2020, 72 : 27 - 46
  • [38] Salivary IgA as biomarker of disease activity in Systemic Lupus Erythematosus
    Romero, Sandra
    Saul Sanchez-Salguero, Erick
    Jose Torres-Ruiz, Jiram
    Nunez-Alvarez, Carlos
    Santos-Argumedo, Leopoldo
    Chacon-Salinas, Rommel
    Gomez-Martin, Diana
    Luis Maravillas-Montero, Jose
    [J]. JOURNAL OF IMMUNOLOGY, 2019, 202 (01):
  • [39] Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices
    Griffiths, B
    Mosca, M
    Gordon, C
    [J]. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2005, 19 (05): : 685 - 708
  • [40] Antiendothelial cell antibodies and systemic lupus erythematosus disease activity
    Resplandy, F
    Dupuy, R
    Seigneur, M
    Constans, J
    Conri, C
    Boisseau, MR
    [J]. 20TH EUROPEAN CONFERENCE ON MICROCIRCULATION, 1998, : 395 - 397